The use of fluoroquinolones in gonorrhoea: the increasing problem of resistance

@article{Dan2004TheUO,
  title={The use of fluoroquinolones in gonorrhoea: the increasing problem of resistance},
  author={Michael Dan},
  journal={Expert Opinion on Pharmacotherapy},
  year={2004},
  volume={5},
  pages={829 - 854}
}
  • M. Dan
  • Published 1 April 2004
  • Medicine, Biology
  • Expert Opinion on Pharmacotherapy
The recent re-emergence of gonorrhoea in developed countries has been accompanied by the rise and spread of gonococcal resistance to the fluoroquinolones. In the 1980s fluoroquinolones were considered an important addition to the arsenal of agents used to treat gonorrhoea. They proved to be excellent drugs for this indication, including infections caused by penicillinase-producing and tetracycline-resistant strains of Neisseria gonorrhoeae. However, as gonococci have a well-recognised potential… 
Antimicrobial Resistance of Neisseria gonorrhoeae Isolated in Korea
TLDR
The minimum inhibitory concentrations of ceftriaxone were within the susceptible range for all isolates, but MIC creep has been apparent and one cefixime-nonsusceptible isolate (0.5 ㎍/㎖) was found.
The use of cephalosporins for gonorrhea: the impending problem of resistance.
TLDR
Few good options exist or are in development for treating cephalosporin-resistant isolates, as most have had multidrug resistance.
The use of cephalosporins for gonorrhea: the impending problem of resistance
TLDR
Few good options exist or are in development for treating cephalosporin-resistant isolates, as most have had multidrug resistance.
Antibiotic resistance in Neisseria gonorrhoeae is diminishing available treatment options for gonorrhea: some possible remedies
  • J. Tapsall
  • Medicine, Biology
    Expert review of anti-infective therapy
  • 2006
TLDR
Over-reliance on antibiotic treatment as a disease control measure in settings with high disease rates and poor control of antibiotic usage is a significant contributor to the antimicrobial resistance reported.
Mechanisms of the formation of Neisseria gonorrhoeae resistance to cephalosporins
TLDR
The authors describe the prospects of studying the mosaic structure of the penA gene encoding the РВР2 protein as well as spatial structure of this protein and emphasize the importance of mutations in porB, penA, mtrR, penB and ponA genes in the development of Neisseria gonorrhoeae resistance to β-lactam antibiotics.
An insight into the drug resistance profile & mechanism of drug resistance in Neisseria gonorrhoeae
TLDR
It is necessary not only to monitor drug resistance and optimise treatment regimens, but also to gain insight into how gonococcus develops drug resistance to prevent the occurrence of drug resistance against existing and new drugs.
What management is there for gonorrhea in the postquinolone era?
  • J. Tapsall
  • Medicine, Biology
    Sexually transmitted diseases
  • 2006
TLDR
A recent and sustained increase in fluoroquinolone resistance in N. gonorrhoeae isolated in France in the past 15 years is described and the mechanisms of resistance in QRNG are multiple and thus far chromosomally mediated, but changes in the target sites for quinolones, gyrase, and topoisomerase intravenously are pivotal.
Antibiotic Resistance in Neisseria
TLDR
O Ongoing surveillance programs are essential for identifying and limiting the emergence of cephalosporin- and multidrug-resistant gonococci in the future, a problem which to a lesser extent threatens the closely related pathogen, N. meningitidis.
Gonococcal antimicrobial resistance: the implications for public health control
TLDR
Of major concern is the emergence of antimicrobial resistance in N gonorrhoeae to the extended-spectrum cephalosporins as evidenced by observations of increasing gonococcal minimum inhibitory concentrations of both ceftriaxone and cefixime and treatment failures in some patients treated with these agents.
The Gonococcus fights back: is this time a knock out?
  • D. Lewis
  • Medicine, Biology
    Sexually Transmitted Infections
  • 2010
TLDR
To delay the emergence of extensively drug-resistant gonorrhoea, public health systems require strengthening and novel strategies need implementing to enhance the therapeutic lifespan of the few antimicrobial agents that the authors have left.
...
1
2
3
...

References

SHOWING 1-10 OF 284 REFERENCES
Fluoroquinolone resistance in Neisseria gonorrhoeae.
TLDR
Monitoring for fluoroquinolone resistance is now critical for ensuring adequate treatment of infections with resistant strains and for maximizing the time during which fluoroquolones may be used to treat gonorrhea.
Fluoroquinolone-resistant Neisseria gonorrhoeae--San Diego, California, 1997.
  • Medicine, Biology
    MMWR. Morbidity and mortality weekly report
  • 1998
TLDR
The results of an investigation in 1997 of two cases of gonococcal infection in the United States with strains with a higher level of fluoroquinolone resistance than reported previously are described; clinical treatment failure occurred in one case.
Update on quinolone resistance in Neisseria gonorrhoeae
  • J. Zenilman
  • Biology, Medicine
    Current infectious disease reports
  • 2002
TLDR
Designing public health strategies to contain quinolone-resistant N. gonorrhoeae will be difficult because it is independent from other plasmid- and chromosomally-mediated resistance determinants; nearly all isolates to date have been sensitive to cephalosporins and spectinomycin.
Fluoroquinolone resistance in Neisseria gonorrhoeae--Colorado and Washington, 1995.
  • Medicine, Biology
    MMWR. Morbidity and mortality weekly report
  • 1995
TLDR
The recent occurrence of resistant cases in Denver and Seattle suggests that clinically important resistance to the fluoroquinolones may be emerging.
Antibiotic-Resistant Neisseria gonorrhoeae: The Calm before Another Storm?
TLDR
Data from these case reports and the pharmacokinetics characteristics of even the most active agents suggest that no fluoroquinolone is likely to be reliable as single-dose therapy for infection due to gonococci with high-level resistance.
The Emergence of Neisseria gonorrhoeae with Decreased Susceptibility to Ciprofloxacin in Cleveland, Ohio: Epidemiology and Risk Factors
TLDR
An epidemiologic investigation assessed risk factors associated with the presence of N. gonorrhoeae that had decreased susceptibility to ciprofloxacin in men with gonorrhea at one sexually transmitted disease clinic in Cleveland, Ohio.
Increasing Resistance of Neisseria gonorrhoeae in West and Central Africa: Consequences on Therapy of Gonococcal Infection
TLDR
This study illustrates the high frequency of resistant gonococci in Africa and shows that tetracycline‐resistant N. gonorrhoeae have become highly endemic in different geographic areas of the continent.
Quinolone resistance in Neisseria gonorrhoeae
TLDR
The emergence of QRNG is probably related to antimicrobial misuse and overuse, in particular long-term suppressive or subtherapeutic doses.
Antibiotic susceptibility of Neisseria gonorrhoeae in Trinidad and Tobago.
TLDR
The resistance rates demonstrated in this study are sufficiently significant to preclude theUse of penicillin and tetracycline in the STD clinics and to justify the use of newer antimicrobials.
Characteristics of Neisseria Gonorrhoeae Isolated in Australia Showing Decreased Sensitivity to Quinolone Antibiotics
TLDR
Although spread of quinolone resistance in gonococci in Australia is unlikely to be rapid, if these antibiotics are used in therapy, treatment regimens with higher rather than lower dosages of qu inolone antibiotics should be employed.
...
1
2
3
4
5
...